Patents Examined by Qiuwen Mi
  • Patent number: 10993897
    Abstract: The present invention provides a topical formulation and method of use where the formulation comprises macqui berry or a macqui berry extract containing anthocyanins having a very high oxygen radical absorbance capacity (ORAC). The formulation provides the macqui berry in a stabilized form which includes a glucuronide or glycuronide, a photostabilizing agent, encapsulation, or light—and/or air-blocking packaging.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: May 4, 2021
    Assignee: Tracie Martyn International, Inc.
    Inventor: Marius Morariu
  • Patent number: 10993978
    Abstract: Compositions and methods include a synergistically effective combination of glycerol and Phyllanthus emblica extract for increasing muscle volume in response to an exercise stimulus of the corresponding muscle or muscle region.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: May 4, 2021
    Assignee: KLZ HOLDINGS, LLC
    Inventors: Tim N. Ziegenfuss, Hector L. Lopez, Bruce W. Kneller
  • Patent number: 10993970
    Abstract: Prebiotic compositions for infants containing medical-grade honey are provided. Methods of supplementing infant milk formula or breast milk with medical-grade honey to enhance growth and improve colonic microbiota are also provided.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: May 4, 2021
    Inventor: Hany Z. Aly
  • Patent number: 10987391
    Abstract: A method for combining energy supplements such as energy drinks or food items with Cannabis extract. The energy supplements include at least one energizing active ingredient of variable potency. The Cannabis extract may be produced of variable potency from at least one strain of Cannabis. The agglomerated product may be produced in various forms of food or beverages. When used, the agglomerated product may provide the typical effects of Cannabis in addition to the added energy and focus provided by energy supplements.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: April 27, 2021
    Inventor: Slate Podaima
  • Patent number: 10987384
    Abstract: A fermented pollen-based composition is provided which is made by treating pollen grains with one or more natural potassium sources selected from coconut water, coconut milk, raw honey, or honeydew honey, to naturally stimulate germination of the pollen, then incubating the germinated pollen, optionally with one or more additional components selected from beeswax, oils, enzyme-containing components derived from fruit, and probiotic components, wherein the resulting composition comprises a plurality of bioactive components selected from low molecular weight peptides, fatty acids, esterified flavonoids, dicaffeoyl quinic acid isomers and dicaffeoyl tartaric acid ester or ether compounds. Topical skin compositions including the fermented pollen-based composition as an active ingredient are also provided.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: April 27, 2021
    Assignee: DECIMA HEALTH LIMITED
    Inventor: Iona Weir
  • Patent number: 10982070
    Abstract: A crystalline pigment or colorant composition having high color intensity and/or low sugar content, and methods and processes of preparation. The composition may comprise purified fruit and/or vegetable color juices.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: April 20, 2021
    Assignee: E. & J. Gallo Winery
    Inventors: Joseph Rossi, Sundeep Kattamuri
  • Patent number: 10975244
    Abstract: The present invention relates to a valuable product in the form of a flavonoid-containing phenol mixture having intense red coloration and to a method for obtaining a valuable-substance phase, more particularly a red-colored phase, from a native substance mixture.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: April 13, 2021
    Assignee: GEA Mechanical Equipment GmbH
    Inventors: Steffen Hruschka, Wladislawa Boszulak, Daniel Michael Martel
  • Patent number: 10967017
    Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, GRIFOLA FRONDOSA polysaccharide, ANGELICAE SINENSIS RADIX oil and CINNAMOMI CORTEX oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-? 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: April 6, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Minghua Hu, Fangli Ma, Yuanyuan Wang, Chung Wah Ma, Renhuai Cong, Lingyun Xiao
  • Patent number: 10967021
    Abstract: The present invention provides a new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Besides the pharmaceutical use, the thylakoid extract enters the composition of food or food supplements, or medication for its innocuity and its capacity to provide a diet enriched in anti-oxidants and anti-inflammatory compounds. Therefore, in accordance with the present invention is provided the use of athylakoid extract in the making of an oral composition for treating preventing a disease or disorder involving the formation of reactive oxygen species or inflammation. Also is provided a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orality administering an effective dose of a thylakoid extact.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: April 6, 2021
    Assignee: GROUPE SANTÉ DEVONIAN
    Inventors: Marc Purcell, Réjean Drouin
  • Patent number: 10967016
    Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, MORINDAE OFFICINALIS RADIX polysaccharide, POLYGONATI RHIZOMA polysaccharide, ANGELICAE SINENSIS RADIX oil and MYRISTICAE SEMEN oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, enhances body immune function, restores normal immune surveillance function, decreases VEGF and TGF-?1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: April 6, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Yuanyuan Wang, Fangli Ma, Renhuai Cong, Minghua Hu, Chung Wah Ma
  • Patent number: 10960041
    Abstract: A method for alleviating ultraviolet damage includes administering to a subject in need thereof a composition containing an ethyl acetate-extracted product of Sedum formosanum. The ethyl acetate-extracted product of Sedum formosanum is prepared by a process including the steps of (a) extracting Sedum formosanum with a solution of monohydric alcohol to obtain a alcohol-extracted product from Sedum formosanum; (b) partitioning the alcohol-extracted product with water and n-hexane to obtain an aqueous layer and a n-hexane layer; and (c) partitioning the aqueous layer obtained in step (b) with ethyl acetate, followed by collecting an ethyl acetate layer thus formed to obtain the ethyl acetate-extracted product of Sedum formosanum.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: March 30, 2021
    Assignee: ESEN Biotech Inc.
    Inventors: I-Cheng Lai, Alicia Lai, Heng-Ju Lai
  • Patent number: 10960043
    Abstract: A nutritious fruit juice supplement with the major components coming from Passiflora edulis and Galium aparine, which contain several compounds including flavonoids, phenolic compounds, alkaloids, cyanogenic compounds, glycosides, vitamins A and C, riboflaurniacin, iron, magnesium, phosphorous, potassium, copper, terpenoid compounds, and protein. The innovating processing techniques increase the activity of antioxidant and anti-cancer properties already found in the fruit juice from P. edulis and G. aparine and create new compounds that should have additional antioxidant and anti-cancer properties.
    Type: Grant
    Filed: October 6, 2018
    Date of Patent: March 30, 2021
    Inventor: John Muturi
  • Patent number: 10960037
    Abstract: A method of treating neurological condition in a subject by administration of a neuroprotective composition of a mixture of two or more triterpenes. Alzheimer's disease, Huntington's disease, stroke or Parkinson's disease are treated by administering a therapeutically effective amount of the neuroprotective composition to a subject.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: March 30, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Otis C. Addington, Robert A. Newman
  • Patent number: 10953065
    Abstract: Disclosed is a nano-emulsion formulation of saffron and a method of preparation thereof. The method includes the steps of triturating saffron with liquid nitrogen. Preparing an ultrasonic assisted extract in a polar or non-polar solvent. Preparing a nano-emulsion using the extract and one or more surfactants, including tween and span.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: March 23, 2021
    Inventors: Hamed Ahari, AmirAli Anvar, Mahdi Rahimian, Sara Allahyari Beik, Sima Moradi
  • Patent number: 10953055
    Abstract: An extract of seeds of Emblica officinalis which has triterpenoids and hydroxycinnamic acids is provided. A blend of extracts of seeds of Emblica officinalis which includes an extract of seeds of Emblica officinalis having triterpenoids and hydroxycinnamic acids and an extract of seeds of Emblica officinalis having fatty acids, such as, alpha linolenic acid, linoleic acid and oleic acid is provided. Methods of preparing the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided. Methods of treatment administering the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: March 23, 2021
    Inventor: Benny Antony
  • Patent number: 10952945
    Abstract: The present invention relates to pharmaceutical and cosmetic formulations containing an extract of Echinacea and linoleic acid derivatives, particularly emulsions containing an extract of Echinacea and linoleic acid derivatives as an active agent combination, and the use of such formulations as medicines, medicinal products and/or cosmetics.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: March 23, 2021
    Inventors: Michael Soeberdt, Christoph Abels, Ulrich Knie
  • Patent number: 10952948
    Abstract: The present invention relates generally to methods and compositions useful to cleanse, exfoliate, smooth, moisturize, hydrate, and/or improve the appearance and/or condition of skin and/or hair using a composition including shea butter, PEG-50 shea butter, and/or hydrated silica.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: March 23, 2021
    Assignee: Mary Kay Inc.
    Inventors: Kim Wilson, Geetha Kalahasti
  • Patent number: 10953058
    Abstract: Disclosed is a method for treating skin. The method can include topically applying to skin in need thereof a composition comprising effective amounts of Arctium lappa root extract and Epilobium angustifolium extract to reduce expression of a pro-inflammatory cytokine of IL-8, IL-2, or TNF-? in the skin.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: March 23, 2021
    Assignee: Mary Kay Inc.
    Inventors: Michelle Hines, Tiffany Carle
  • Patent number: 10946056
    Abstract: A method of slowing progression of an amyloid disease by administration of cactus mucilage extract from Opuntia ficus-indicia is presented. Both gelling and non-gelling cactus mucilage extracts were found to induce changes in the secondary structures of the amyloid beta peptides thus interfering with formation of A? fibrils and aggregation of A? fibrils into plaques.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: March 16, 2021
    Assignee: University of South Florida
    Inventors: Norma A. Alcantar, David Morgan, Zeinab Veisi, Leonid Breydo, Vladimir N. Uversky, Ryan G. Toomey, Tunan Peng, Eva Stephanie Lobbens
  • Patent number: 10945943
    Abstract: The present invention provides an extract of dragon fruit flower. The extract of dragon fruit flower is prepared by the following steps. A dragon fruit flower is provided. The dragon fruit flower is dried and then cut into pieces. An extraction process is provided, which includes a mixing step, a heating step, a cooling step, a reheating step, and an extracting step. In the mixing step, the pieces of the dragon fruit flower are mixed with an alcohol solution to obtain a mixture for processing the following steps. After finishing the extraction process, the mixture is separated into a solid part and a liquid part, wherein the liquid part includes the extract of the dragon fruit flower.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: March 16, 2021
    Assignee: M.H. Biotechnology Corporation, Ltd.
    Inventor: Hsiang-Hsun Chiang